Tamoxifen Citrate (Nolvadex) ZPHC — 100 × 20 mg tablets

Tamoxifen Citrate (Nolvadex®) — Selective Estrogen Receptor Modulator (SERM)
100 film-coated tablets × 20 mg
Purpose: competitive ER antagonist in breast tissue; core agent for PCT and estrogen-control research.
PCT examples: 40 mg/day × 7–14 days → 20 mg/day × 14–28 days; supports LH/FSH rebound and endogenous testosterone.
Estrogen management: useful for gynecomastia-prone protocols; can be combined with AIs when needed.
Interactions/cautions: avoid concurrent strong CYP2D6 inhibitors; caution with history of thromboembolism; contraindicated in pregnancy.
QC: ≥ 99% API purity (HPLC); GMP tablet press; tamper-evident cap with authenticity scratch-code.
*For laboratory research use only. Not approved as a medicinal product.*, Tamoxifen Citrate (Nolvadex) ZPHC — 100 × 20 mg tablets, 49, USD, ,